4//SEC Filing
Schmidt William K 4
Accession 0001192482-21-000613
CIK 0001716947other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:08 PM ET
Size
6.0 KB
Accession
0001192482-21-000613
Insider Transaction Report
Form 4
Schmidt William K
Chief Medical Officer
Transactions
- Award
Stock Option
2021-06-30+69,142→ 69,142 totalExercise: $3.22Exp: 2026-02-04→ Common Stock (69,142 underlying)
Footnotes (1)
- [F1]On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.
Documents
Issuer
Ensysce Biosciences, Inc.
CIK 0001716947
Entity typeother
Related Parties
1- filerCIK 0001301122
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:08 PM ET
- Size
- 6.0 KB